Clinical trial
Impact of Smoking Cessation on Sleep - 5
NCT00132821 · National Institute on Drug Abuse (NIDA), NIH · Completed
Key facts
| NCT number | NCT00132821 |
|---|---|
| Title | Impact of Smoking Cessation on Sleep - 5 |
| Official title | Impact of Smoking Cessation on Sleep |
| Lead sponsor | National Institute on Drug Abuse (NIDA), NIH |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Tobacco Use Cessation, Sleep Disorders |
| Intervention type | Drug |
| Interventions | Bupropion, Transdermal Nicotine Patch, Placebo Bupropion, Placebo transdermal nicotine patch |
| Enrollment | 59 |
| Start date | Aug 1, 2005 |
| Primary completion | May 1, 2009 |
| Completion | May 1, 2009 |
| First posted | Aug 22, 2005 |
| Last update posted | Jan 12, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: